A graduate of the University of Virginia, Thompson Dean serves Avista Capital Partners as the co-managing partner and CEO. Working alongside a team of veteran business professionals, Thompson Dean guides Avista in its investments and portfolio management.
Toward the end of 2016, Avista portfolio company Lantheus Holdings, Inc., which provides diagnostic medical imaging solutions, announced that its stockholders intended to make 2.5 million shares of common stock available for sale. Building on the 500,000 shares that Lantheus stockholders originally made available, these 2.5 million shares will become available alongside an additional 1 million shares of common stock offered by Lantheus.
This offering is made pursuant to the filing of an effective shelf registration with the Securities and Exchange Commission, with Lantheus making clear that it will not benefit from any of the proceeds generated through the sale of existing stockholder shares. The offering is underwritten by Credit Suisse, one of the world’s leading multinational financial services companies.
